Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-212333
Filing Date
2011-08-05
Accepted
2011-08-05 16:10:22
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 556922
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9706
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9688
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ANDCHIEF FINANCIAL OFFICER dex321.htm EX-32.1 5136
  Complete submission text file 0001193125-11-212333.txt   2211569

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ino-20110630.xml EX-101.INS 281739
6 XBRL TAXONOMY EXTENSION SCHEMA ino-20110630.xsd EX-101.SCH 15216
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ino-20110630_cal.xml EX-101.CAL 42964
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ino-20110630_lab.xml EX-101.LAB 124163
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ino-20110630_pre.xml EX-101.PRE 78876
Mailing Address 11494 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1318
Business Address 11494 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1318 858 597-6006
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330024450 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14888 | Film No.: 111014414
SIC: 3841 Surgical & Medical Instruments & Apparatus